Jagsonpal Pharmaceuticals Market Cap

Jagsonpal Pharmaceuticals has a market cap or net worth of 13.80 billion as of April 29, 2026. Its market cap has decreased by -3.70% in one year.

Market Cap

13.80B

Enterprise Value

12.82B

Revenue

2.99B

Ranking

n/a

PE Ratio

32.58

Stock Price

209.07

Market Cap Chart

Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 13.80B, a decrease of -21.73%. That is a compound annual growth rate of -0.93%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	13.80B	7.29%
Dec 31, 2025	12.86B	-20.68%
Dec 31, 2024	16.22B	58.61%
Dec 29, 2023	10.22B	4.69%
Dec 30, 2022	9.77B	108.36%
Dec 31, 2021	4.69B	150.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beta Drugs	13.49B
Sakar Healthcare	14.00B
Ind-Swift Laboratories	11.91B
Windlas Biotech	18.13B
Indoco Remedies	19.05B
Sigachi Industries	8.39B
Solara Active Pharma Sciences	23.00B
Orchid Pharma	28.75B

Market Cap Rankings